Scott Kuwada to Colonic Neoplasms
This is a "connection" page, showing publications Scott Kuwada has written about Colonic Neoplasms.
Connection Strength
0.898
-
Majer M, Akerley W, Kuwada SK. Oncologists' current opinion on the treatment of colon carcinoma. Anticancer Agents Med Chem. 2007 Sep; 7(5):492-503.
Score: 0.266
-
Kuwada SK, Kuang J, Li X. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. J Biol Chem. 2005 May 13; 280(19):19027-35.
Score: 0.224
-
Kuwada SK, Scaife CL, Kuang J, Li X, Wong RF, Florell SR, Coffey RJ, Gray PD. Effects of trastuzumab on epidermal growth factor receptor-dependent and -independent human colon cancer cells. Int J Cancer. 2004 Mar 20; 109(2):291-301.
Score: 0.210
-
Li X, Kuang J, Shen Y, Majer MM, Nelson CC, Parsawar K, Heichman KA, Kuwada SK. The atypical histone macroH2A1.2 interacts with HER-2 protein in cancer cells. J Biol Chem. 2012 Jun 29; 287(27):23171-83.
Score: 0.092
-
Wong RF, Khosla R, Moore JH, Kuwada SK. Consider colonoscopy for young patients with hematochezia. J Fam Pract. 2004 Nov; 53(11):879-84.
Score: 0.055
-
Rice PL, Kelloff J, Sullivan H, Driggers LJ, Beard KS, Kuwada S, Piazza G, Ahnen DJ. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Mol Cancer Ther. 2003 Sep; 2(9):885-92.
Score: 0.050